As soon as the genetic testing company 23andMe filed for bankruptcy[1] on March 23, 2025, concerns about what would happen to the personal information contained in its massive genetic and health information database were swift and widespread. A few days after, a U.S. judge ruled that the company could sell its consumer data[2] as part of the bankruptcy.
The attorneys general of several states warned their citizens to delete...